UTI - Healthcare Fund (Direct)
UTI Mutual Fund · benchmark Nifty 500 TRI · 13.8 years old · AMFI code 120782
B (middle of the peer group), score 51.8 out of 100. Describes the past, not a forecast.
Returns against the index
| Period | Fund | Index (TRI) | Difference | Rank in category |
|---|---|---|---|---|
| 6 months | 15.5% | 2.5% | +13.0% | 9 / 17 |
| 1 year | 17.3% | -1.0% | +18.3% | 11 / 16 |
| 3 years (a year) | 24.5% | 12.0% | +12.5% | 4 / 11 |
| 5 years (a year) | 16.9% | 9.7% | +7.2% | 4 / 7 |
Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.
Risk
Portfolio
Top 10 holdings, September 2026 portfolio.
Common questions
What is the NAV of UTI - Healthcare Fund (Direct plan)?
₹388.33 on 5 Nov 2026 (Growth option).
What is the expense ratio of UTI - Healthcare Fund (Direct)?
1.33% a year; the Regular plan's is 2.21%.
What return has UTI - Healthcare Fund given over 3 years?
24.5% a year (Direct plan) over the 3 years to 5 Nov 2026, against 12.0% for the Nifty 500 total-return index.
What does UTI - Healthcare Fund invest in?
Its largest holdings are EQ - SUN PHARMACEUTICALS INDUSTRIES, EQ - DIVIS LABORATORIES LTD., EQ - DR REDDYS LABORATORIES LTD., with 44 stocks in all (September 2026 portfolio).
How is UTI - Healthcare Fund rated?
B: 5 of 11 Direct plans in Thematic: Pharma & Healthcare, on its track record. This describes the past and is not a recommendation.
Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from UTI Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.